Odyssey Health, Inc., a medical company, focuses on developing medical products.
Most recently: . Entry into a Material Definitive Agreement. On January 30, 2026, Odyssey Health, Inc. (the “Company”), entered into four Amendments No. 12, to the Convertible (2026-02-03).
—
Market Cap
—
Revenue
—
Net Income
Odyssey Health, Inc., a medical company, focuses on developing medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and PRV-001 and PRV-002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was founded in 2014 and is based in Las Vegas, Nevada.